| Thanks to Lead SoCalBio Sponsors |  |
Take Advantage of SoCalBio's Group Purchasing Program to Cut the Cost of Doing Business Vendor ShowcaseFor Translation Services |
Looking for Legal Help with IP, Business, Labor and Immigration
Matters? | |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| | Emerging Company Presentations | The Following Companies Will Make Presentations
During the SoCalBio Conference on September 17 Allvivo Vascular APOImmune Applied Biocode BioSeven Biotic Labs CytomX Therapeutics DxTerity Diagnostics Dynacardia Fibron iCo Therapeutics
| ImaginAB ImmunGene Inscent K-Space Kineta Lerner Medical Devices Med BioGene MiCardia preSage Biosciences
| |
RSVP now to attend the conference |
| Conference Highlight | Abraxis Bioscience's Founder and Chairman, Dr. Patrick Soon-Shiong, Will Speak About Bio/Pharma Partnership Opportunities During the 11th SoCalBio Investor Conference  Dr. Soon-Shiong (photo right) will join a panel including Stephen de Laszlo, Ph.D., Director Scientific Liaison, Infectious Diseases, Merck, Hakan Sakul, Ph.D., Sr. Dir. & Gobal Head of Diagnostics, Molecular Medicine Group, Pfizer Global R&D, and Matt Busch, Director Finance Business Development, Amgen to discuss collaboration opportunities between emerging biotech firms and established pharma companies. Organized by Conference lead sponsor, Ernst & Young, this panel is one of five breakout sessions offered during the conference on funding and partnering opportunities in this challenging economy. Also See: |
Upcoming SoCalBio Business Mixers | - September 30, 4:00 - 7:00 pm
 SoCalBio Networking Forum in Ventura County (Westlake Village Inn)
Focus: Innovation and Protecting Your Intellectual Property in a Changing Patent Regime ... More Info
Focus: Why Bioscience Companies Should Care About Social Media ... More Info
|
| New SoCalBio Members |  Replenish, Inc.
(Pasadena)
Co-founded by Sean Caffey, MD (photo right), Replenish is a medical device firm developing an intraocular drug delivery micro-pump to deliver the right amount of medications for eye problems such as glaucoma and age-related macular degeneration... Learn more  Reshape Medical(San Clemente) A development-stage medical device manufacturer focused on the development of non-surgical weight loss devices. The company's main product is an intragastric balloon that can be used as aids in the treatment of obese or overweight patients.... Learn more
 Jinn Su, Patent AttorneyJinn Su (photo right) is a patent attorney trained in both engineering and the law. He works with companies to protect their inventions in the medical device, software, and semiconductor fields ... Learn more |
| Partnerships | ImmunoCellular Therapeutics of Woodland Hills Locks a $ 32 Million Pact with Roche  "We are extremely pleased to have generated the interest of such a significant player in the international healthcare market," remarked Manish Singh, Ph.D., president and chief executive officer of IMUC (photo right). "We believe that Roche's interest serves as a validation of our strong portfolio of antibody therapies designed to diagnose and treat cancers and may increase our ability to attract further partnership activities going forward" ... Read press release ImmunoCellular: Roche Pact Validates Pipeline Potential
ImmunoCellular Therapeutics is an emerging cancer immunotherapy company that is developing therapeutic and diagnostic product candidates taking aim at the root cause of the disease, cancer stem cells (CSCs), based on two distinct technology platforms - active (cancer vaccines) and passive (monoclonal antibodies or mAbs). Pact with Roche validates company's approach to cancer treatment .... Learn more |
| Clinical Studies | MiCardia Announces Completion of Enrollment in "DYANA" European CE Study This "DYANA" (Dynamic Annuloplasty Activation) study is designed to support submission for CE mark of the firm's Dynaplasty technology for heart valve repairing in Europe ... Read more Edwards Lifesciences Completes Enrollment in U.S. Trial for Transcatheter Heart Valve The multi-center PARTNER (Placement of AoRTic traNscathetER valves) Trial assigns patients into one of two arms: a "non-surgical" arm, in which the Edwards SAPIEN valve is compared to non-surgical treatments, and a "surgical" arm, in which the Edwards SAPIEN valve is compared to traditional surgical aortic valve replacement. The primary endpoint for the PARTNER Trial is based on one-year follow-up of each patient enrolled; this evaluation has been underway and is continuing ... Read more |
| Product Approvals | ISTA Pharmaceuticals' Eye Drug Gets FDA Nod Bepreve -- indicated for the treatment of ocular itching associated with allergic conjunctivitis in patients two years and above -- is expected to be available to ophthalmologists and patients in the United States in the fourth quarter of 2009. The Irvine-based Ista expects to recognize revenues from the drug from this year and is expanding its sales force for this purpose ... Read more Spectrum's Zevalin OK'd for New Use The U.S. Food and Drug Administration's full approval allows the Irvine-based Spectrum to market Zevalin as a first-line consolidation therapy for non-Hodgkin's lymphoma (NHL) patients -- a move that is expected to significantly widen the number of patients treated with the drug and breathe new life into moribund sales. Before last Friday, Zevalin's approval only covered NHL patients whose tumors continued to grow despite previous treatments. First approved in 2001, Zevalin saw sales of just $11 million last year... Read more |
| Spin-Offs | The Northridge-headquartered Pharmavite LLC Launches New Direct-to-Consumer Company The new company -- Pharmavite Direct LLC -- is an internet-based, direct-to-consumer sales and marketing company offering a supplement program that provides a customized daily vitamin plan tailored to fit individuals' unique nutritional needs. Based on information provided by the user, the program can deliver up to 100,000 different recommended vitamin combinations. "The Nature Made vitaminID program was created in direct response to consumers' desire for individualized approaches to their general health and wellness routines," said Gary Kuchta, president, Pharmavite Direct... Read more |
About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| |
|
Editor:
